Shantanu Gaur bought $24k of ALUR
Chief Executive Officer at ALLURION TECHNOLOGIES, INC.. 8,000 shares at an average of $3.06, traded May 19, 2025, filed May 21, 2025.
Score components
- +25RoleCEO
- 0Trade size$24k at market
- +10Relative to holdingsHoldings up 100%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying2 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -18.0%, 3m -24.7%, 6m -50.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-075780, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 19, 2025 | POpen-market purchase Common Stock | +8,000 | $3.06 | $24k | 16,000 | May 21, 2025 |
Related signals
Other insiders at ALLURION TECHNOLOGIES, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 35Weak | ALURsell ALLURION TECHNOLOGIES, INC. | Michael R Davin director | $4,918 3,212 shares | -100% | |
| 38Weak | ALURbuy ALLURION TECHNOLOGIES, INC. | Shantanu Gaur Chief Executive Officer | $27k 8,000 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.